European Medicines Agency

🐝 Why does bee health matter to all of us? In the latest #InsideEMA podcast, we explore bee health, from the challenges of developing medicines for them to how EMA helps ensure they are safe, effective and of high quality. 🎙️ Listen now! #BeeHealth #AnimalHealth

We’ve just recommended a new treatment option for adults with metastatic pancreatic cancer for authorisation in the EU. Find out more about the medicine and how it was evaluated: www.ema.europa.eu/en/news/ema-... 🧪#MedSky

The agenda of EMA's human medicines committee #CHMP is now published. Find out what medicines will be discussed this month 💊💉 www.ema.europa.eu/en/events/co... The committee highlights will be released on Friday.

🐄 EMA recommends an EU marketing authorisation for a vaccine that helps protect cattle against lumpy skin disease by reducing clinical signs and virus levels in the blood. #animalwelfare #veterinary Read more:

📢 From January 2027, a pilot helping sponsors develop stronger clinical trial applications in the EU will become a permanent initiative. This is known as the Accelerating Clinical Trials in the EU (ACT EU) advice 🔗 Learn more www.ema.europa.eu/en/news/clin... #PublicHealth #medsky 🧪 #SciComm

🧪 EMA will develop a roadmap by end-2026 to drive change in how women’s health is considered in medicines development and regulation. It follows a workshop with 100+ experts and stakeholders. Read more: www.ema.europa.eu/en/news/wome... #medsky #womenshealth

❤️ This World Heart Day, hear personal experiences of living with heart conditions, alongside simple tips on how to look after your heart and take care of your cardiovascular health. Learn more about the EMA workshop: www.ema.europa.eu/en/events/em...

Discover our new pharmacogenomics webpage, featuring information on how genetic variation can influence a response to medicines. Explore data from centrally authorised medicines and scientific guidance for medicine developers 🔗 www.ema.europa.eu/en/human-reg... #PublicHealth #medsky 🧪 #SciComm

🌿 Herbal medicines have a long history. Watch the joint FDA/EMA workshop on herbal medicinal and botanical products to find out how regulators ensure their quality, safety and good use 📺 www.ema.europa.eu/en/events/re... @fda.gov

EMA experts explore why we shouldn't focus on setting a requirement for a number of clinical trials. One pivotal trial, or two? What matters is generating evidence that addresses patients’ needs and supports a positive benefit–risk balance. Read the article: www.nature.com/articles/s41...

📢 EMA recommends: 12 new medicines for approval, including four medicines for cancer. Read more here: 🔗 www.ema.europa.eu/en/news/meet... #PublicHealth #medsky 🧪 #SciComm

Did you know some foods and drinks can affect how your medicine works? 🍊☕🍌 Your package leaflet tells you what to be mindful of, including foods, drinks and alcohol. When in doubt, ask your pharmacist or doctor. Keep safe. Read the leaflet.🧪 #SciComm Learn more: www.ema.europa.eu/en/about-us/...

The agenda of EMA's human medicines committee #CHMP is now published. Find out what medicines will be discussed this month 💊💉 www.ema.europa.eu/en/events/co... The committee highlights will be released on Friday.

What are we doing for women’s health? We’re working to ensure women’s needs are considered in medicine development, evaluation and use, for a wide range of areas: from #endometriosis to #pregnancy and #menopause. Learn more here. www.ema.europa.eu/en/human-reg... #medsky 🧪 #womenshealth

We have just started a review of injectable iron-containing medicines following concerns about the risk of low blood phosphate levels and related bone problems. Find out more in #PRAC highlights: www.ema.europa.eu/en/news/meet...

Good news! A new EU supply chain has been put in place to end the shortage of Visudyne, a medicine used to treat adults with certain serious eye conditions, which will ensure access to patients across the EU. Find out more more: www.ema.europa.eu/en/news/new-...

🎙️ New #InsideEMA episode! What is it like to be an EMA trainee? From regulatory science and policy to learning, networking and life in Amsterdam, current trainees share their experience of working at the European Medicines Agency. 🎧 💊 🌍

🚀 We are launching a new voluntary data submission pilot for innovative alternatives to animal testing. Companies can submit data generated using new approach methodologies and receive tailored scientific feedback from EMA 👉 www.ema.europa.eu/en/news/volu... #PublicHealth #medsky 🧪 #SciComm

What are the regulatory research priorities for #AI use in the #medicine lifecycle in the EU❓ Find out now from this open-access article: ascpt.onlinelibrary.wiley.com/doi/10.1002/... #medsky #AIResearch 🧪

“We need to think about strategies to make #vaccination easier, not more complicated,” said Marco Cavaleri, our head of public-health threats, in a Nature article on combined MMR vaccines versus separate #measles, mumps and rubella shots in children. Read more: www.nature.com/articles/d41... 🧪

Questions about childhood vaccination❓Combined measles, mumps and rubella (MMR) vaccines have been used worldwide for several decades to effectively protect children against these diseases. Their safety profile is well-established. Read more: www.ema.europa.eu/en/human-reg... #medsky 🧪

Since 2022, #ECDC & @ema.europa.eu have been working together through the VMP to generate evidence on the effectiveness and safety of vaccines used in Europe. The evidence supports public health and regulatory decision-making across the EU/EEA.

𝗛𝗼𝘄 𝗱𝗼 𝘄𝗲 𝗸𝗻𝗼𝘄 𝗵𝗼𝘄 𝘄𝗲𝗹𝗹 𝘃𝗮𝗰𝗰𝗶𝗻𝗲𝘀 𝘄𝗼𝗿𝗸 𝗼𝗻𝗰𝗲 𝘁𝗵𝗲𝘆 𝗮𝗿𝗲 𝗶𝗻 𝘂𝘀𝗲? That's one of the questions the Vaccine Monitoring Platform (VMP) helps answer ➡️ www.ecdc.europa.eu/en/about-ecd... Today a research agenda for 2026–2029 was published, setting out the priority diseases & research questions.

A few days on, we're still reflecting on an unforgettable WorldPride Amsterdam. 🌈 EMA became the first EU agency to join a WorldPride event, sailing with our United for Health boat. Together, we showed that inclusive science makes health better for everyone. 💙 Read more:

🎙️ New Inside EMA podcast: Can medicines one day be developed without animal testing? Discover how innovation and the 3Rs (replace, reduce, refine) are helping shape the future of medicines development while protecting patient safety. 🎧 Listen now

📢 EMA recommends: 12 new medicines for approval, including one medicine for plaque psoriasis. Read more here: 🔗 www.ema.europa.eu/en/news/meet... 🧪 #PublicHealth #medsky #SciComm

We're looking for a Clinical Trials Data Management Specialist to join our team in Amsterdam. If you have at least 3 years' relevant experience, and skills in clinical trial data management or statistical programming then apply now! careers.ema.europa.eu/job/EMA-Amst...

Cervical cancer kills hundreds of thousands of women, although much of it is preventable. Equitable vaccine design must reflect the HPV types driving disease in the highest-burden populations. INSIDE VIEW: Dr Marco Cavaleri @ema.europa.eu 📖 ➡️ & 🔁🙏 healthpolicy-watch.news/a-regional-a...

Innovation thrives through collaboration. We're strengthening our partnership with EISMEA to support Europe's health innovators. Together, we'll help researchers, start-ups and SMEs bring safe, effective health solutions to patients faster. Read more: www.ema.europa.eu/en/news/ema-...

During its meeting in July, our safety committee, the PRAC, agreed new safety information on: 🔹desogestrel- and etonogestrel-containing #contraceptives 🔹Litfulo, a medicine to treat #alopecia areata. #pharmacovigilance #medsky #Scicomm www.ema.europa.eu/en/news/meet...

EMA fast tracks the review of a #medicine for metastatic pancreatic #cancer, a disease with a high unmet medical need. Read more in our news announcement: www.ema.europa.eu/en/news/ema-... #medsky #scicomm #pancreaticcancer 🧪

The European Medicines Agency is looking for a Communication Officer to join our team in Amsterdam. If you have at least 2 years' experience in communications, strong writing skills in English and experience in web, media relations or social media, apply now! careers.ema.europa.eu/job/EMA-Amst...

This week marked 20 years of EMA’s Patients’ and Consumers’ Working Party – two decades of partnership, progress and patient-centered impact. Since its creation in 2006, it has helped ensure their perspectives are meaningfully reflected in medicines regulation in the EU. Thank you

Women live longer, but often spend more years in poor health. EMA is working to support medicines that are better tailored to women’s needs. Join our Women’s Health Workshop (📆28–29 Sept) and help shape a more inclusive future. #medsky 🧪 #womenhealth www.ema.europa.eu/en/news/ema-...

🧪 How does EMA's PRIME scheme help accelerate medicine development? Watch our new video where Kevin Cunningham (EMA PRIME Scientific Coordinator) and Outi Mäkki-Ikola (Finnish Medicines Agency Fimea) explain how PRIME supports innovation and faster patient access to medicines.

📢 EMA recommends: 6 new medicines for approval, including one medicine for Parkinson's disease. Read more here 🔗 www.ema.europa.eu/en/news/meet... #PublicHealth #medsky 🧪 #SciComm

Up to 90% of pregnant or breastfeeding women use medicines, yet safety data is limited for many treatments. In our latest podcast, EMA’s Corinne de Vries discusses why this gap exists and how we can build better evidence for informed decisions. 🎙️

EATG is proud to announce its participation in the European Medicines Agency’s (EMA) “United for Health” float during the #WorldPride2026 Canal Parade in Amsterdam on 1 August 2026. Read more: www.eatg.org/news/eatg-to... @ema.europa.eu

(1/4) The European Union has been training researchers for 30 years 🧪 This is also a story about Nobel Prize scientist Marie Skłodowska-Curie: link.europa.eu/CmWVpd Curious to know more? Curiosity was her main trait 👇